ELI LILLY & Co is 258.0x more valuable than Tango Therapeutics, Inc. by market capitalization ($1.070 T vs $4.15 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TNGX | LLY |
|---|---|---|
| Market cap | $4.15 B | $1.070 T |
| US-listed rank | #1540 | #10 |
| Revenue (latest FY) | $62.38M | $65.18B |
| Net income (latest FY) | -$101.60M | $20.64B |
| Net margin | -162.9% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 382 | 989 |
ELI LILLY & Co is 258.0x more valuable than Tango Therapeutics, Inc. by market capitalization ($1.070 T vs $4.15 B).
In their latest fiscal years, Tango Therapeutics, Inc. reported $62.38M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Tango Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.